Board summary
Key figures
53,655
Registered population
59.1% aged 18–64
20.5%
Aged 65+
ICB 14.9% · England 17.9%
7.7%
In IMD quintile 1
ICB 40.7% · England 21.0%
~3,514
Core20 residents (est.)
Resident basis; registered basis ~4,144 · see page 3
9,115
Hypertension register
+2.15% in 3 yrs · England +5.60%
566
SMI register
21.1% of Trafford (LAD)'s
1,583
COPD register
Reviews -1.33% in 3 yrs
Forecast to 2030
9,673
Hypertension patients, 2030
+558 on today
74.8%
QRISK ≥20% on statins, 2030
+2.60pp over 3 yrs
5.3%
Cancer prevalence, 2030
England 4.5%
Three things the board should see
Asthma annual reviews fall behind national coverage.
Annual review coverage is 56.4% (England 65.7%) after a -8.7% three-year change (England +4.4%), leaving an estimated 1,945 unreviewed patients, which may reflect recall.
Heart failure review coverage trails all comparators.
Coverage across 810 registered patients is 69.4% (Trafford 76.6%, ICB 80.0%, England 78.5%) following a -4.1% three-year change, which could reflect appointment capacity.
Strong blood pressure and diabetes biometric control.
Hypertension control aged 80+ reached 83.8% (England 81.2%, up +5.4% over three years), alongside 58.6% HbA1c control in non-frail diabetes (England 57.4%).
Population, age and ethnicity
Registered patients aged 65+ reach 20.5%, exceeding borough, regional and England averages
Trafford West PCN comprises 53,655 registered patients across member practices, using GP-registered population bases. The PCN is older than benchmarks: 20.5% (11,004 patients) are aged 65+, compared with 17.1% in Trafford (LAD), 14.9% in NHS Greater Manchester Integrated Care Board, and 17.9% in England. Working-age adults aged 18-64 make up 59.1% (31,689 patients; LAD 61.0%, ICB 63.3%, England 62.7%), while children aged 0-17 represent 20.4% (10,962 patients; LAD 21.8%, ICB 21.8%, England 19.6%), concentrating in Partington Family Practice (25.6%) and Partington Central Surgery (25.0%). Recorded Gypsy or Irish Traveller and Roma groups are each 0.0%.
Age profile
65+: ICB 14.9%, England 17.9%
Older people · falls rows are Trafford (LAD) local-authority (LA) data, not PCN
| Measure | Local | North West | England | Period |
|---|---|---|---|---|
| Falls admissions, 65+, per 100,000 (Trafford LA) | 2,087 | 2,071 | 1,958 | 2024/25 |
| Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN) | 85.0% | 82.9% | 81.9% | 2024/25 |
| Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN) | 58.6% | 56.6% | 57.4% | 2024/25 |
| Falls admissions, 65 to 79, per 100,000 (Trafford LA) | 950 | 1,021 | 955 | 2024/25 |
| Falls deaths, all ages, per 100,000 (Trafford LA) | 22.7 | 18.2 | 14.8 | 2022‑24 |
Deprivation and Core20
Core20 deprivation is moderate overall but concentrated entirely within two Partington practices
Trafford West PCN's Core20 share is 7.7%, below England (21.0%), Trafford (8.2%) and NHS Greater Manchester ICB (40.7%). Deprivation is concentrated in two practices: Partington Central Surgery has the highest concentration (40.6%; 1,603 estimated patients), while Partington Family Practice carries the largest volume (2,541 estimated patients; 37.8%). The other four practices record 0.0%. The discrepancy between resident Core20 estimates (3,514) and practice-level modelled counts (4,144) is consistent with differing population bases.
% of patients in IMD quintile 1, by practice
Dashed line: England 21.0% · right column: Core20 patients, registered basis
PLUS groups and inclusion health
PLUS groups and inclusion health
566
SMI register
1.05% recorded prevalence
383
Learning disability register
0.71% recorded prevalence
21
Care homes, 531 beds
In the PCN catchment
8.7%
Provide unpaid care
Trafford (LAD), Census 2021
Recorded learning disability prevalence is 0.7% (383 patients), above Trafford (LAD 0.5%), NHS Greater Manchester Integrated Care Board (0.6%), and England (0.6%). Severe mental illness prevalence is 1.1% (566 patients; Trafford (LAD) 1.1%, NHS Greater Manchester Integrated Care Board 1.1%, England 1.0%). The PCN catchment includes 21 care homes with 531 beds.
Severe mental illness: physical health checks
SMI blood pressure checks reached 86.9% (England 83.4%) with three-year change of +0.4 pp (England +4.4 pp), while BMI recording reached 86.9% (England 82.1%). Multi-element physical reviews require systematic recall to prevent monitoring from stagnating.
Clinical focus: hypertension and lipids
Clinical focus: hypertension and lipids
9,115
Hypertension register
+2.15%
Register growth, 3 yrs
Trafford (LAD) +4.39% · England +5.60%
+3.88pp
BP control, under 80
≤140/90 · +4.29pp aged 80+
+558
More patients by 2030
Forecast 9,673 (17.69%)
Hypertension case-finding and control
Hypertension recorded prevalence is 17.0% (9,115 patients), above England (15.2%), Trafford (15.1%), and NHS Greater Manchester ICB (14.4%), though three-year register growth was +2.1% against +5.6% nationally. Treatment to target reached 71.1% (England 70.3%), with 67.7% controlled under age 80 (England 67.8%) and 83.8% aged 80+ (England 81.2%), while 90.1% had a recent blood pressure check. However, annual review coverage for 810 heart failure patients fell 4.1% over three years (England +8.7%) to 69.4%, trailing England (78.5%), Trafford (76.6%), and the ICB (80.0%). Heart failure review coverage sits notably below all comparators despite strong blood pressure control, indicating that post-diagnostic cardiovascular recall warrants prioritisation.
Lipids and statins
Lipid-lowering therapy reaches 69.3% of patients with QRISK ≥ 20% (England 63.6%) and 74.4% with CKD (England 70.3%). In diabetes with CVD, statin coverage is 84.5% (England 84.4%), but fell 0.8% over three years (England +1.0%). Slipping statin coverage in diabetic CVD points to a recall opportunity for high-risk secondary prevention.
| Measure | Items | Cost / item | ICB | England | Annual spend |
|---|---|---|---|---|---|
| Lipid-modifying, 2026 | 133,811 | £1.90 | £1.94 | £1.86 | £254,241 |
| Cardiovascular (all), 2025 | 182,855 | £2.67 | £3.15 | £3.33 | £488,223 |
In 2026, the PCN prescribed 133,811 lipid-regulating drug items at £1.90 per item (England £1.86, Trafford £1.98, NHS Greater Manchester ICB £1.94). This spend is £5,352 more than at England's unit cost across 133,811 items, though unit cost does not measure efficiency or clinical case-mix.
Clinical focus: respiratory, cancer register and children
Clinical focus: respiratory, cancer register and children
Respiratory
−8.73%
Asthma reviews, PCN 3-yr % change
+4.44%
Asthma reviews, England 3-yr % change
−1.71%
Asthma prevalence, PCN 3-yr % change
Asthma prevalence is 8.8% (Trafford 7.3%, England 6.6%) across 4,457 registered patients, alongside youth prescribing of 2,163 items per 1000 population aged 5-19 (England 1,488). However, annual asthma reviews fell 8.7% over three years (England +4.4%) to 56.4% (England 65.7%), leaving an estimated scale gap of 1,945 unreviewed patients. COPD prevalence is 2.9% (1,583 patients; England 1.9%) with review coverage at 77.6% (England 76.4%). Prioritising proactive asthma recall could address this substantial review shortfall.
Cancer register and children's immunisation
Cancer recorded prevalence is 4.7% across 2,538 registered patients (England 3.8%). In childhood immunisations, 6-in-1 coverage at 12 months is 88.9% (England 91.0%). At age five, MMR first-dose coverage reached 95.2% while second-dose coverage is 88.3%, a 6.9 pp dose difference between first and second dose coverage in the same cohort. Targeted pre-school recall could help close the second-dose immunisation gap.
Dashed line: 95% national coverage target · solid tick: England
Early cancer diagnosis
Early cancer diagnosis
55.6%
Greater Manchester ICB, stage 1–2
55.3%
England, 2022
75%
National ambition by 2028
~2,270
Extra early-stage cases a year to reach the ambition
| Stage 1–2 share by cancer type, 2022 | Greater Manchester ICB | England | No usable stage | Staged cancers |
|---|---|---|---|---|
| Lung | 40.4% | 33.8% | 15% | 2,193 |
| Prostate | 61.7% | 53.2% | 14% | 1,788 |
| Breast | 82.5% | 85.4% | 19% | 1,758 |
| Bowel | 46.3% | 47.0% | 19% | 1,427 |
| Skin cancer | 84.5% | 87.8% | 27% | 580 |
In 2022, 55.6% of known-stage cancers in NHS Greater Manchester ICB (6,491 of 11,679) were diagnosed at stage 1 or 2, above England (55.3%) but 19.4 percentage points below the 75.0% national ambition by 2028 (a scale gap of 2,268.2 early cases). Staged completeness was 70.8% (11,679 of 16,492). Early-stage shares ranged from 22.4% for oesophagus (77 of 344) to 82.5% for breast (1,451 of 1,758). Staging reflects wider system performance, not PCN delivery. Within the PCN, cervical screening coverage (25-49 years) was 74.4%, while Partington Central Surgery recorded 63.5%. Addressing screening variation across member practices provides a local preventative focus alongside broader system pathways.
Cancer waits, diagnostics and community services
Cancer waits, diagnostics and community services
Cancer waits and diagnostics, Jul 2026 (provisional)
In July 2026, Manchester University NHS Foundation Trust met the 28-day faster diagnosis standard at 80.1%, ahead of Northern Care Alliance NHS Foundation Trust (75.2%), the ICB (79.5%) and England (79.3%), but behind Bolton NHS Foundation Trust (80.5%). However, its 62-day referral to treatment performance was 72.8%, trailing the 85.0% standard, Northern Care Alliance NHS Foundation Trust (78.6%) and the ICB (75.7%), though above England (71.2%) and Bolton NHS Foundation Trust (69.7%). Patients waiting 6+ weeks for diagnostics reached 11.7% for MRI and 13.0% for cystoscopy. Provider treatment backlogs mean referred patients face delays reaching definitive first treatment.
| Pathways within standard (%) | Manchester | Northern Care Alliance | Bolton | Greater Manchester ICB | England |
|---|---|---|---|---|---|
| 28-day faster diagnosis (75%) | 80.06 | 75.20 | 80.48 | 79.53 | 79.32 |
| 31-day treatment (96%) | 92.54 | 94.54 | 96.50 | 96.49 | 92.50 |
| 62-day referral to treatment (85%) | 72.85 | 78.65 | 69.66 | 75.73 | 71.16 |
| Diagnostic waits over 6 weeks (%) | Manchester | Northern Care Alliance | Bolton | England |
|---|---|---|---|---|
| MRI | 11.68 | 5.09 | 2.05 | 21.40 |
| CT | 14.66 | 4.10 | 19.40 | 9.92 |
| Echocardiography | 4.91 | 31.48 | 3.48 | 28.48 |
| Colonoscopy | 4.51 | 40.04 | 1.33 | 30.83 |
| Gastroscopy | 29.35 | 36.48 | 2.06 | 29.02 |
| All 15 DM01 tests | 8.98 | 15.71 | 15.78 | 23.14 |
| Community services activity | Trafford residents | Greater Manchester ICB |
|---|---|---|
| Care contacts | 41,705 | 573,310 |
| Referrals | 7,445 | 94,470 |
| Patients with a contact | 13,840 | 183,535 |
Community services (residents of Trafford), Jun 2026 (provisional). In June 2026, 51.3% of community service contacts for Trafford residents (21,375 of 41,705) were for adults aged 65 and over. These provisional figures represent borough resident activity rather than PCN delivery. With 20.5% of PCN patients aged 65+, primary care may experience high shared demand with community nursing teams.
Practice variation and patient experience
QOF vaccination achievement spans 58.0 percentage points across member practices
In 2025/26, overall QOF achievement ranged from 77.5% at Partington Central Surgery to 97.7% at Urmston Group Practice (England 92.5%). Vaccination and immunisation achievement spanned 58.0 pp, from 24.5% at Flixton Road Medical Centre to 82.5% at Urmston Group Practice (England 55.2%). Checking clinical coverage and personalised care adjustments would test whether point shortfalls reflect delivery gaps.
GP Patient Survey by practice
| Practice | Responses | % in IMD Q1 | Phone easy | Request led to appt | Overall good |
|---|---|---|---|---|---|
| Davyhulme | 122 | 0.0 | 69.2% | 77.6% | 86.7% |
| Primrose Surgery | 122 | 0.0 | 82.4% | 59.5% | 83.2% |
| Flixton Road | 114 | 0.0 | 70.5% | 71.3% | 80.7% |
| Urmston | 111 | 0.0 | 51.5% | 70.1% | 80.2% |
| Partington | 120 | 37.8 | 65.4% | 74.6% | 78.3% |
| Partington | 82 | 40.6 | 62.0% | 69.9% | 63.3% |
| England | — | ~21 | 56.9% | 71.6% | 76.7% |
Where the PCN lags
Seventeen of 25 tracked measures trail England's three-year change, led by annual reviews
Seventeen of 25 tracked measures trail England's three-year change. The widest relative declines sit in annual chronic reviews: asthma reviews fell 8.7% (England +4.4%) and heart failure reviews fell 4.1% (England +8.7%), where recorded review coverage stands at 69.4% (England 78.5%). Conversely, the PCN outpaced England in breast screening coverage growth (+20.9% vs +8.4%) and non-frail diabetes HbA1c control, which rose 7.4% (England +4.4%) to reach 58.6% (England 57.4%).
3-year change · PCN vs England
Bars show the direction and scale of relative change. Orange: PCN · Grey: England.
Asthma reviews
Heart failure reviews
COPD reviews
BP check (SMI)
Hypertension register
Breast screening (53-70)
BP control, 80+
Diabetes HbA1c control
What the data can't tell us: gaps and local assets
What the data can't tell us: gaps and local assets
| Local assets and voluntary sector | PCN | Trafford (LAD) | Asset | PCN | Trafford (LAD) |
|---|---|---|---|---|---|
| Care homes (catchment) | 21 (531 beds) | n/a | Schools (catchment) | 51 | n/a |
| Children's centres | 4 | 16 | Places of worship | 25 | 119 |
| Libraries | 2 | 9 | Primary schools (LA maintained) | 6 | 39 |
| Primary academies | 8 | 17 | Special schools | 1 | 3 |
0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.
Options for the PCN
Options for the PCN
Each option in full
Option 1
Proactive asthma annual review recall
Asthma annual review coverage is 56.4% across 4,457 registered patients, below England (65.7%) by 9.3 pp and Trafford (63.7%) by 7.3 pp, leaving an estimated scale gap of 1,945 unreviewed patients. Moderate effort to run.
Evidence base: the annual asthma review is the process gap between the register and outcomes.
Policy anchor: Core20PLUS5 chronic respiratory disease priority.
Option 2
Heart failure review and functional assessment
Heart failure annual review coverage is 69.4% across 810 registered patients, below England (78.5%) by 9.2 pp, Trafford (76.6%) by 7.2 pp, and the ICB (80.0%) by 10.6 pp. For discussion: practices could establish a proactive recall list for heart failure reviews including functional capacity assessment, starting in high-deprivation practices. Moderate effort to run.
Option 3
Standardised SMI physical health check recall
SMI blood pressure check recording across 566 registered patients changed by +0.4 pp from 2023 to 2025, a difference of -4.0 percentage points compared with England (+4.4 pp) and -4.6 percentage points compared with Trafford (+5.0 pp), though the current rate is 3.5 percentage points above England. Moderate effort to run.
Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.
Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.
Provenance and audit trail
Provenance and audit trail
Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.
| Recommendation | Indicator(s) | Policy anchor | Data level |
|---|---|---|---|
| Targeted Partington Core20 outreach (p3) | Core20 cohort (IMD quintile 1) | Core20PLUS5 · 10YHP equity test | PCN |
| Systematic SMI physical health recall (p4) | Record of a BP check in the last 12 months for patients on the MH register (denominator incl. PCAs) | MHIS · From Harm to Hope | PCN |
| Heart failure annual review recall (p5) | Patients with heart failure who had a review in the last 12 months including the assessment of functional capacity (denominator incl. PCAs) | — | PCN |
| Pre-school MMR booster catch-up (p6) | MMR dose 2 coverage at age 5 | 10YHP sickness to prevention · 95% target | PCN |
| Cervical screening recall audit (p7) | Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs) | Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026 | Practice |
| Option 1 · Proactive asthma annual review recall (p12) | Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) | Core20PLUS5 respiratory | PCN |
| Option 2 · Heart failure review and functional assessment (p12) | Heart failure register · Patients with heart failure who had a review in the last 12 months including the assessment of functional capacity (denominator incl. PCAs) | — | PCN |
| Option 3 · Standardised SMI physical health check recall (p12) | Severe mental illness register · SMI register with a BP check in the last 12 months · Record of a BP check in the last 12 months for patients on the MH register (denominator incl. PCAs) | MHIS · From Harm to Hope | PCN |
Data sources
Data sources
Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.
| Dataset | Level | Period | Used for |
|---|---|---|---|
| Coplug indicator tables: census, deprivation and QOF measures | PCN & Practice | 2023 to 2025, projected to 2030; 2023 to 2024 | Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12 |
| MHCLG, Rough sleeping snapshot in England: autumn 2025 | Local authority | Autumn 2025 | Pages 2, 4 |
| OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) | PCN | 2024/25 | Pages 2, 4 |
| OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002) | Local authority | 2024/25; 2022-24 | Pages 2, 4 |
| ONS, Census 2021 TS039: provision of unpaid care (age-standardised) | Local authority | Census 2021 | Pages 2, 4 |
| QOF registers, prevalence and care processes (Coplug indicator tables) | Practice | 2023 to 2025, projected to 2030 | Pages 4, 5, 6, 7, 8, 10 |
| UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26 | PCN & Practice | Q1 2025/26 | Pages 4, 6 |
| UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026 | Local authority | 2025/26 season to 28 Feb 2026 | Pages 4, 6 |
| NHS England, Cancer Waiting Times: July 2026 monthly time series with revisions | ICB & Provider | Jul 2026 (provisional) | Pages 7, 8 |
| NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental data | ICB & Local authority | Jun 2026 (provisional) | Pages 7, 8 |
| NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026 | Provider | Jul 2026 | Pages 7, 8 |
| National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022 | ICB | 2022 | Pages 7, 8 |
| NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted) | Practice | Survey Jan-Apr 2026 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domain | Practice | 2025/26 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domain | Practice | 2025/26 | Page 9 |
| Coplug indicator catalogue — definitions, cohorts, policy anchors | Reference | Current | Evidence-base lines, page 13 |
Methods, data-quality notes and limitations
Methods, data-quality notes and limitations
Methods
Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.
Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.
Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.
Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.
